ERASCA INC (ERAS:NASDAQ)
$11.5 0.26 (2.3132%)
Analysed ERASCA INC (ERAS:NASDAQ) News Sources
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO
14-05-2026
fool.com
What to Know About This Fund’s $50 Million Exit From Ascendis Pharma
14-05-2026
fool.com
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
16-05-2026
fool.com
Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference
16-05-2026
marketbeat.com
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More
17-05-2026
fool.com
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
17-05-2026
fool.com
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
17-05-2026
fool.com
Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally
18-05-2026
fool.com
Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
20-05-2026
yahoo.com
Erasca Patent Dispute Puts ERAS-0015 And Investment Case Under Scrutiny
26-05-2026
yahoo.com
What is the current price of ERASCA INC (ERAS:NASDAQ)?
The current price of ERASCA INC (ERAS:NASDAQ) is $11.5.
ERASCA INC (ERAS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ERASCA INC (ERAS:NASDAQ) since the previous trading day is $0.26.
ERASCA INC (ERAS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ERASCA INC (ERAS:NASDAQ) since the previous trading day is 2.3132%.
What is the most recent average sentiment score for ERASCA INC (ERAS:NASDAQ)?
The most recent average sentiment score for ERASCA INC (ERAS:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for ERASCA INC (ERAS:NASDAQ)?
The most recent sentiment for ERASCA INC (ERAS:NASDAQ) is .
SEC-8K** Filing Available For ERASCA INC (ERAS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.